Skip to main content

Table 1 Characteristics of Participating Physicians

From: Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer

Total physician sample (N)

75

100.0%

Number of patients treated with advanced MTC in the last 12 months

  Mean (SD)

26.0 (20.9)

  Median (IQR)

20.0 (8.0–45.0)

Primary medical specialty, (n, %)

  Medical or clinical oncology (oncologist)

40

53.3%

  Hematology-oncology

35

46.7%

Primary practice setting, (n, %)

  Cancer center/tertiary referral treatment center

34

45.3%

  Academic/teaching hospital

13

17.3%

  Other nonteaching hospital

3

4.0%

  Private hospital or clinic

25

33.3%

Number of years in practice managing treatment of oncology patients since fully qualified

  Mean (SD)

14.7 (5.7)

  Median (IQR)

15.0 (10.0–18.0)

Geographic region of practice, (n, %)

  Northeast

19

25.3%

  Midwest

12

16.0%

  South

23

30.7%

  West

21

28.0%

Number of patients for whom data was provided for this study

  Mean (SD)

2.8 (2.0)

  Median (IQR)

2.0 (1.0-4.0)

  Min, Max

1.0

6.0

  1. MTC medullary thyroid cancer, SD standard deviation